Price target upside
Virax Biolabs Group Limited - Ordinary Shares Price Target Upside or Downside
VRAX price target upside based on the current price and analyst average.
Direct answer
Virax Biolabs Group Limited - Ordinary Shares's analyst target implies +799.3%.
The average target is $25.00 compared with a recorded current price of $2.78.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Virax Biolabs Group Limited - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.78
- Average price target
- $25.00
- High price target
- $25.00
- Low price target
- $25.00
- Target upside
- +799.3%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026